+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Caspofungin Market by Indication (Esophageal Candidiasis, Invasive Aspergillosis, Invasive Candidiasis), Formulation (Lyophilized Powder, Pre-mixed Solution), Product Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Caspofungin Market by Indication (Esophageal Candidiasis, Invasive Aspergillosis, Invasive Candidiasis), Formulation (Lyophilized Powder, Pre-mixed Solution), Product Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Caspofungin Market by Indication (Esophageal Candidiasis, Invasive Aspergillosis, Invasive Candidiasis), Formulation (Lyophilized Powder, Pre-mixed Solution), Product Type, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5968352
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Caspofungin market is evolving in response to shifting treatment needs for severe fungal infections, ongoing pharmaceutical innovation, and complex global supply chain factors. Senior decision-makers navigating this space face a landscape shaped by advances in therapy protocols, regulatory shifts, and strategic competition.

Market Snapshot: Caspofungin Market Trends and Growth Drivers

The Caspofungin Market grew from USD 643.80 million in 2024 to USD 673.47 million in 2025. It is expected to continue growing at a CAGR of 4.39%, reaching USD 833.45 million by 2030. Robust demand is being shaped by caspofungin’s increasingly central role in complex antifungal treatment strategies, rapid advances in formulation technology, and the global expansion of critical care facilities. Market responsiveness to regulatory developments and supply chain adaptations remains a key focus for stakeholders as operational environments evolve.

Scope & Segmentation of the Caspofungin Market

  • Indications: Includes esophageal candidiasis, invasive aspergillosis, and invasive candidiasis, each with distinct clinical applications and therapeutics requirements.
  • Formulation Types: Covers lyophilized powder and pre-mixed solution, with operational impacts on storage, preparation, and administration.
  • Product Types: Branded portfolio solutions versus generic alternatives, impacting pricing, service arrangements, and procurement strategies.
  • End Users: General and specialty clinics, private and public hospitals—each segment with unique adoption patterns, evaluative processes, and workflow integration.
  • Distribution Channels: Hospital pharmacy (serving acute/critical care) and retail pharmacy (chain and independent outlets serving outpatient needs).
  • Geographical Regions: Americas (including United States, Canada, and key Latin American countries), Europe, Middle East & Africa (UK, Germany, EMEA nations), and Asia-Pacific (China, India, Japan, and others).
  • Industry Players: Analysis includes major organizations such as Merck & Co., Sandoz International, Teva, Viatris, Natco Pharma, Biocon, Cipla, Dr. Reddy’s, Apotex, and Fresenius Kabi, as well as emerging biopharmaceutical firms.

Key Takeaways for Senior Decision-Makers

  • Caspofungin’s clinical significance grows as healthcare systems confront increased resistance and complex fungal pathogens, driving ongoing research into optimal combinations and dosing strategies.
  • Advances in formulation, such as ready-to-use pre-mixed solutions and improved lyophilized powders, have enhanced both operational efficiency and patient safety in busy clinical settings.
  • Branded and generic competition intensifies, with companies leveraging manufacturing enhancements and strategic alliances to address both quality assurance and market penetration challenges.
  • Specialty and general care environments increasingly rely on formulary committees and procurement managers to evaluate real-world efficacy, cost-effectiveness, and workflow fit for caspofungin use.
  • Regional dynamics—including regulatory harmonization in Europe, procurement innovation in EMEA nations, and collaborative delivery channels in Asia-Pacific—shape localized growth and access strategies.

Tariff Impact on Caspofungin Market Operations

Recent United States tariffs on key raw materials and active pharmaceutical ingredients have directly influenced supply chain costs and procurement strategies for caspofungin. Manufacturers and distributors have responded with more stringent contract terms, alternative sourcing routes, and adjustments to inventory management approaches. Hospitals and clinics now emphasize just-in-time inventory tactics and closer supplier collaboration, increasing the sector’s focus on resilience and contingency logistics. Strategic planning for tariff impact has become critical for ensuring uninterrupted patient access despite policy and economic fluctuations.

Rigorous Methodology & Data Sources

This report integrates qualitative and quantitative research, beginning with an extensive review of scientific literature, regulatory filings, and trial data. Primary interviews with infectious disease specialists, pharmacists, and procurement leaders underpin the analysis, supported by independent data from public health agencies and relevant industry bodies. All findings are strengthened through data triangulation for validity and actionable clarity.

Why This Caspofungin Market Report Matters

  • Synthesizes clinical, operational, and regulatory dynamics to provide a comprehensive, actionable perspective for leaders shaping antifungal strategy.
  • Highlights critical opportunities in product innovation, segment growth, and supply chain adaptability—empowering evidence-based decisions across commercial and hospital settings.
  • Equips stakeholders with competitive intelligence and regional insights necessary to drive value creation and respond proactively to shifting market pressures.

Conclusion

The Caspofungin market reflects a dynamic intersection of clinical advancement, operational adaptation, and strategic competition. This report delivers essential intelligence to guide senior executives in optimizing their antifungal solution portfolios and sustaining long-term market leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising number of invasive fungal infections in intensive care units driving surge in caspofungin usage
5.2. Patent expirations of flagship caspofungin formulations catalyze entry of biosimilar competitors and price erosion
5.3. Strategic alliances between generic drug manufacturers and regional distributors enhance caspofungin market penetration in Asia Pacific
5.4. New clinical trial data supports use of caspofungin in combination regimens against multidrug resistant Candida auris infections
5.5. Implementation of antimicrobial stewardship protocols in hospitals optimizes caspofungin dosing to mitigate fungal resistance emergence
5.6. Regulatory approvals expanding prophylactic caspofungin indications for hematopoietic stem cell transplant recipients boost market growth
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Caspofungin Market, by Indication
8.1. Introduction
8.2. Esophageal Candidiasis
8.3. Invasive Aspergillosis
8.4. Invasive Candidiasis
9. Caspofungin Market, by Formulation
9.1. Introduction
9.2. Lyophilized Powder
9.3. Pre-mixed Solution
10. Caspofungin Market, by Product Type
10.1. Introduction
10.2. Branded
10.3. Generic
11. Caspofungin Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. General Clinics
11.2.2. Specialty Clinics
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
12. Caspofungin Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Retail Pharmacy
12.3.1. Chain Pharmacy
12.3.2. Independent Pharmacy
13. Americas Caspofungin Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Caspofungin Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Caspofungin Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Sandoz International GmbH
16.3.3. Teva Pharmaceutical Industries Ltd.
16.3.4. Viatris Inc.
16.3.5. Natco Pharma Limited
16.3.6. Biocon Limited
16.3.7. Cipla Limited
16.3.8. Dr. Reddy's Laboratories Limited
16.3.9. Apotex Inc.
16.3.10. Fresenius Kabi AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CASPOFUNGIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CASPOFUNGIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CASPOFUNGIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CASPOFUNGIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CASPOFUNGIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CASPOFUNGIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CASPOFUNGIN MARKET: RESEARCHAI
FIGURE 26. CASPOFUNGIN MARKET: RESEARCHSTATISTICS
FIGURE 27. CASPOFUNGIN MARKET: RESEARCHCONTACTS
FIGURE 28. CASPOFUNGIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CASPOFUNGIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CASPOFUNGIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CASPOFUNGIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CASPOFUNGIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CASPOFUNGIN MARKET SIZE, BY ESOPHAGEAL CANDIDIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CASPOFUNGIN MARKET SIZE, BY ESOPHAGEAL CANDIDIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CASPOFUNGIN MARKET SIZE, BY INVASIVE ASPERGILLOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CASPOFUNGIN MARKET SIZE, BY INVASIVE ASPERGILLOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CASPOFUNGIN MARKET SIZE, BY INVASIVE CANDIDIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CASPOFUNGIN MARKET SIZE, BY INVASIVE CANDIDIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CASPOFUNGIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CASPOFUNGIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRE-MIXED SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRE-MIXED SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CASPOFUNGIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CASPOFUNGIN MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CASPOFUNGIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CASPOFUNGIN MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CASPOFUNGIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CASPOFUNGIN MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CASPOFUNGIN MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CASPOFUNGIN MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CASPOFUNGIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CASPOFUNGIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CASPOFUNGIN MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CASPOFUNGIN MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CASPOFUNGIN MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CASPOFUNGIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CASPOFUNGIN MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CASPOFUNGIN MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CASPOFUNGIN MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CASPOFUNGIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. CANADA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. CANADA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. CANADA CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. CANADA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 104. CANADA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 105. CANADA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 106. CANADA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 107. CANADA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. CANADA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. CANADA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. CANADA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. MEXICO CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 115. MEXICO CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CASPOFUNGIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. GERMANY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 195. GERMANY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. GERMANY CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 202. GERMANY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 203. GERMANY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. GERMANY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. GERMANY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. GERMANY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. GERMANY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. FRANCE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 211. FRANCE CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 212. FRANCE CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 213. FRANCE CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. FRANCE CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. FRANCE CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. FRANCE CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. FRANCE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. FRANCE CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. ITALY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. ITALY CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. ITALY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. ITALY CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. ITALY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. ITALY CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 250. ITALY CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 251. ITALY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. ITALY CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. ITALY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ITALY CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. ITALY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. ITALY CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. SPAIN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. SPAIN CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. SPAIN CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. SPAIN CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. SPAIN CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. SPAIN CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. SPAIN CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. SPAIN CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 266. SPAIN CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 267. SPAIN CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. SPAIN CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. SPAIN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SPAIN CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. SPAIN CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. DENMARK CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 322. DENMARK CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 323. DENMARK CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 324. DENMARK CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 325. DENMARK CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. DENMARK CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. DENMARK CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. DENMARK CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. DENMARK CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 330. DENMARK CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 331. DENMARK CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 332. DENMARK CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 333. DENMARK CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. DENMARK CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. DENMARK CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 336. DENMARK CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 337. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 338. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 339. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 340. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 353. QATAR CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 354. QATAR CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 355. QATAR CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 356. QATAR CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 357. QATAR CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 358. QATAR CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 359. QATAR CASPOFUNGIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 360. QATAR CASPOFUNGIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 361. QATAR CASPOFUNGIN MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 362. QATAR CASPOFUNGIN MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 363. QATAR CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 364. QATAR CASPOFUNGIN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 365. QATAR CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. QATAR CASPOFUNGIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. QATAR CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 368. QATAR CASPOFUNGIN MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 369. FINLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 370. FINLAND CASPOFUNGIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 371. FINLAND CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 372. FINLAND CASPOFUNGIN MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 373. FINLAND CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 374. FINLAND CASPOFUNGIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 375. FINLAND CASPOFUNGIN MARKET SIZE, BY END USER, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Caspofungin market report include:
  • Merck & Co., Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Natco Pharma Limited
  • Biocon Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Apotex Inc.
  • Fresenius Kabi AG

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 673.47 Million
Forecasted Market Value ( USD ) by 2030 $ 833.45 Million
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Caspofungin - Global Strategic Business Report - Product Image

Caspofungin - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Cryptococcosis Market by Drug Class (Azoles, Echinocandins, Polyenes), Indication (Cryptococcal Meningitis, Disseminated Cryptococcosis, Pulmonary Cryptococcosis), Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cryptococcosis Market by Drug Class (Azoles, Echinocandins, Polyenes), Indication (Cryptococcal Meningitis, Disseminated Cryptococcosis, Pulmonary Cryptococcosis), Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Fungal Keratitis Treatment Market by Treatment Modality (Surgical Interventions, Systemic Antifungals, Topical Antifungals), Drug Class (Azoles, Echinocandins, Polyenes), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Fungal Keratitis Treatment Market by Treatment Modality (Surgical Interventions, Systemic Antifungals, Topical Antifungals), Drug Class (Azoles, Echinocandins, Polyenes), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Antifungal Drugs Market Report by Drug Class, Indication, and Region 2024-2032 - Product Image

Antifungal Drugs Market Report by Drug Class, Indication, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Febrile Neutropenia Drug Pipeline Analysis Report 2025 - Product Image

Febrile Neutropenia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From

About the Caspofungin Market

Caspofungin is an antifungal drug used to treat a variety of fungal infections, including those caused by Candida species. It is a member of the echinocandin class of antifungal drugs, which are used to treat serious fungal infections in immunocompromised patients. Caspofungin is typically used in combination with other antifungal drugs, such as amphotericin B or fluconazole, to treat infections that are resistant to other antifungal agents. It is also used to treat infections caused by Aspergillus species, which are often difficult to treat. Caspofungin is an important drug in the treatment of infectious diseases, as it is effective against a wide range of fungal infections. It is also well tolerated, with few side effects. As such, it is an important part of the infectious diseases drugs market. Companies in the caspofungin market include Merck & Co., Pfizer, Astellas Pharma, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.